Novartis Investigator Site

Erlangen

0 studies enrolling now · 1 studies all time

What they study most

Systemic Sclerosis, Scleroderma

Studies at this site

• Efficacy and Tolerability of STI571 (Imatinib Mesylate) for the Treatment of Fibrosis in Participants With Systemic Sclerosis — Completed